Aziz NA - Search Results

1

Body weight is a robust predictor of clinical progression in Huntington disease.

van der Burg JMM, Gardiner SL, Ludolph AC, Landwehrmeyer GB, Roos RAC, Aziz NA. van der Burg JMM, et al. Among authors: aziz na. Ann Neurol. 2017 Sep;82(3):479-483. doi: 10.1002/ana.25007. Epub 2017 Aug 22. Ann Neurol. 2017. PMID: 28779551 Free article.

2

Hypothalamic dysfunction and neuroendocrine and metabolic alterations in Huntington's disease: clinical consequences and therapeutic implications.

Aziz NA, Swaab DF, Pijl H, Roos RA. Aziz NA, et al. Rev Neurosci. 2007;18(3-4):223-51. doi: 10.1515/revneuro.2007.18.3-4.223. Rev Neurosci. 2007. PMID: 18019608 Review.

3

Hypocretin-1 and secondary signs in Huntington's disease.

Roos RA, Aziz NA. Roos RA, et al. Among authors: aziz na. Parkinsonism Relat Disord. 2007;13 Suppl 3:S387-90. doi: 10.1016/S1353-8020(08)70035-X. Parkinsonism Relat Disord. 2007. PMID: 18267269 Review.

4

Intergenerational CAG repeat instability is highly heritable in Huntington's disease.

Aziz NA, van Belzen MJ, Roos RA. Aziz NA, et al. J Med Genet. 2008 Nov;45(11):766. doi: 10.1136/jmg.2008.062133. J Med Genet. 2008. PMID: 18978336 No abstract available.

5

Weight loss in Huntington disease increases with higher CAG repeat number.

Aziz NA, van der Burg JM, Landwehrmeyer GB, Brundin P, Stijnen T; EHDI Study Group; Roos RA. Aziz NA, et al. Neurology. 2008 Nov 4;71(19):1506-13. doi: 10.1212/01.wnl.0000334276.09729.0e. Neurology. 2008. PMID: 18981372 Clinical Trial.

6

Weight loss in neurodegenerative disorders.

Aziz NA, van der Marck MA, Pijl H, Olde Rikkert MG, Bloem BR, Roos RA. Aziz NA, et al. J Neurol. 2008 Dec;255(12):1872-80. doi: 10.1007/s00415-009-0062-8. Epub 2009 Jan 22. J Neurol. 2008. PMID: 19165531 Review.

7

Increased hypothalamic-pituitary-adrenal axis activity in Huntington's disease.

Aziz NA, Pijl H, Frölich M, van der Graaf AW, Roelfsema F, Roos RA. Aziz NA, et al. J Clin Endocrinol Metab. 2009 Apr;94(4):1223-8. doi: 10.1210/jc.2008-2543. Epub 2009 Jan 27. J Clin Endocrinol Metab. 2009. PMID: 19174491

8

Re: Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the genePD study.

Aziz NA, Roos RA. Aziz NA, et al. Mov Disord. 2009 Jun 15;24(8):1253. doi: 10.1002/mds.22588. Mov Disord. 2009. PMID: 19373933 No abstract available.

9

A strategy for finding the optimal deconvolution estimates for hormone secretory kinetics using AutoDecon.

Aziz NA, Roelfsema F, Frölich M, Roos RA, Pijl H. Aziz NA, et al. Anal Biochem. 2009 Aug 1;391(1):69-71. doi: 10.1016/j.ab.2009.05.001. Epub 2009 May 8. Anal Biochem. 2009. PMID: 19427828

10

Leptin secretion rate increases with higher CAG repeat number in Huntington's disease patients.

Aziz NA, Pijl H, Frölich M, van der Graaf AW, Roelfsema F, Roos RA. Aziz NA, et al. Clin Endocrinol (Oxf). 2010 Aug;73(2):206-11. doi: 10.1111/j.1365-2265.2009.03661.x. Epub 2009 Jun 22. Clin Endocrinol (Oxf). 2010. PMID: 19548952

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

331 results

Search Page

Filters